SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Feresiadou A.)
 

Sökning: WFRF:(Feresiadou A.) > Rapidly increasing ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004078naa a2200469 4500
001oai:DiVA.org:uu-352681
003SwePub
008180607s2018 | |||||||||||000 ||eng|
009oai:DiVA.org:liu-151464
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3526812 URI
024a https://doi.org/10.1111/ane.129632 DOI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1514642 URI
040 a (SwePub)uud (SwePub)liu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Berntsson, Shala G.,d 1964-u Uppsala universitet,Neurologi,Uppsala Univ, Sweden4 aut0 (Swepub:uu)shabe360
2451 0a Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden :b Outlier or predecessor?
264 c 2018-05-24
264 1b Hindawi Limited,c 2018
338 a print2 rdacarrier
500 a Funding Agencies|County Council of Uppsala; Uppsala University
520 a OBJECTIVES: Off-label use of rituximab to treat MS patients in Sweden is high, and the need for long-term safety data may not be met. Our objectives were to assess the rate of rituximab prescription in patients with multiple sclerosis in Sweden and, in addition, to evaluate the safety of rituximab in a single centre for patients with multiple sclerosis.MATERIAL AND METHODS: Review of the Swedish MS register was performed to study the number of MS patients treated with rituximab during the last 6 years. Investigation also included a retrospective review of medical files in search for possible side effects/adverse events in all adult patients with MS treated with rituximab at Uppsala University Hospital.RESULTS: Presently, in Sweden the rate of rituximab prescriptions in relation to other annually started of disease- modifying drugs in MS is 53.5%.CONCLUSIONS: The share of MS patients in Sweden who are treated with rituximab is very high, and also rapidly increasing. Taken into account the off-label use, cases with adverse medical conditions that could possibly be related to rituximab use should be reported thoroughly.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng
653 a adverse events
653 a immunomodulatory drugs
653 a multiple sclerosis
653 a off-label prescription
653 a pharmacotherapy
653 a rituximab side effects
700a Kristoffersson, Au Uppsala universitet,Neurologi,Neurology Policlinic, Department of Medical Specialist, Motala General Hospital, Motala, Sweden,Uppsala Univ, Sweden; Motala Gen Hosp, Sweden4 aut
700a Boström, Ingeru Linköpings universitet,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten,Region Östergötland, Neurologiska kliniken i Linköping4 aut0 (Swepub:liu)ingbo67
700a Feresiadou, Amaliau Uppsala universitet,Neurologi,Uppsala Univ, Sweden4 aut0 (Swepub:uu)amafe662
700a Burman, Joachim,d 1974-u Uppsala universitet,Neurologi,Uppsala Univ, Sweden4 aut0 (Swepub:uu)joabu293
700a Landtblom, Anne-Marieu Linköpings universitet,Uppsala universitet,Neurologi,Department of Clinical and Experimental Medicine, Neurology, Medical Faculty, University of Linköping, Linköping, Sweden; Neurology Policlinic, Department of Medical Specialist, Motala General Hospital, Motala, Sweden,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten,Region Östergötland, Neurologiska kliniken i Linköping,Uppsala Univ, Sweden; Motala Gen Hosp, Sweden4 aut0 (Swepub:liu)annla55
710a Uppsala universitetb Neurologi4 org
773t Acta Neurologica Scandinavicad : Hindawi Limitedg 138:4, s. 327-331q 138:4<327-331x 0001-6314x 1600-0404
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-352681
8564 8u https://doi.org/10.1111/ane.12963
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-151464

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy